Cystoid Macular Edema in Retinitis Pigmentosa Patients and its Medical Management: A Case Report
Published: 2024-04-19
Page: 85-91
Issue: 2024 - Volume 7 [Issue 1]
Manal Bouggar *
Department of Ophthalmology, Mohammed V Military Hospital, Mohammed V University of Rabat, Morocco.
Houda Brarou
Department of Ophthalmology, Mohammed V Military Hospital, Mohammed V University of Rabat, Morocco.
Zakaria Chaibi
Department of Ophthalmology, Mohammed V Military Hospital, Mohammed V University of Rabat, Morocco.
Yassine Mouzari
Department of Ophthalmology, Mohammed V Military Hospital, Mohammed V University of Rabat, Morocco.
Abdelbare Oubaaz
Department of Ophthalmology, Mohammed V Military Hospital, Mohammed V University of Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Retinitis Pigmentosa (RP) take in a group of hereditary retinopathies that lead to progressive vision loss ; RP may be complicated by cystoid macular oedema (CMO). A 40-year-old female presented with fluctuant blurred vision for 4 years. Best corrected Visual acuity (BCVA) was 20/20 in both eyes. Examination and imaging showed besides bone spicule pigmentation a macular edema . Currently the patient is under medical treatement. Successful management of RP-CMO should allow to improve quality and quantity of vision in the short term and also slow the progression of central vision loss on the long term. This report describes a case of using carbonic anhydrase inhibitor CAI per os medication to manage CMO secondary to RP in a long term.
Keywords: Retinitis pigmentosa, macular edema, carbonic anhydrase inhibitor, vision loss